BSE filing, NSE: CEEJAY. Summary written from the filing by ALFA Finder's alert engine.
Ceejay Finance Ltd: key numbers
- Share price
- ₹151.00
- Market cap
- ₹52.10 Cr
- Revenue (annual)
- ₹26.54 Cr
- Net profit (annual)
- ₹7.72 Cr
- P/E (TTM)
- 6.5×Sector 19.7×
- Promoter holding
- 59.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ceejay Finance Ltd
All →Ceejay Finance Board Meeting Date
Ceejay Finance will hold a board meeting on 3 November 2026 to consider unaudited results for the quarter and half year. The filing is a future board meeting intimation with proposed agenda only.
Ceejay Finance Annual General Meeting
Ceejay Finance's AGM on September 26, 2026, approved financial statements, a dividend of Rs. 1.50 per share, and director re-appointments with requisite shareholder voting support.
- Value
- ₹0.52 Cr
Ceejay Finance Annual General Meeting
Ceejay Finance Limited will hold its 33rd Annual General Meeting on September 26, 2026, through video conferencing to transact ordinary and special business.
Ceejay Finance Management Change
Ceejay Finance Limited has re-appointed Deepak Patel as Managing Director for a term of 60 months effective September 1, 2026.
Ceejay Finance Q1 FY27 Results: Net Profit ₹2 Cr, Up 17.6% YoY
Ceejay Finance Ltd reported revenue from operations of ₹6.1 Cr (-4.7% YoY) and net profit of ₹2 Cr (+17.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2 Cr · +17.6% YoY
Ceejay Finance Board Meeting Date
Ceejay Finance has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.